$BLGO
BIOLARGO, INC. Stock $blgo

$blgo Overview Financials Valuation SEC Filings Company Website

2017 Form 10-K Financial Statement

#000143774918004890 Filed on March 16, 2018

Income Statement

Concept	2017	2016 Q4	2016
Revenue	$516.2K	$70.00K	$281.1K
YoY Change	83.64%	40.0%	120.33%
Cost Of Revenue	$323.0K	$40.00K	$105.9K
YoY Change	205.07%	33.33%	70.59%
Gross Profit	$193.0K	$30.00K	$175.2K
YoY Change	10.14%	0.0%	167.46%
Gross Profit Margin	37.39%	42.86%	62.34%
Selling, General & Admin	$4.429M	$870.0K	$3.714M
YoY Change	19.24%	27.94%	4.59%
% of Gross Profit	2294.82%	2900.0%	2119.74%
Research & Development	$1.630M	$350.0K	$1.382M
YoY Change	17.95%	59.09%	101.88%
% of Gross Profit	844.56%	1166.67%	788.66%
Depreciation & Amortization	$30.00K	$10.00K	$13.74K
YoY Change	118.4%		25.79%
% of Gross Profit	15.54%	33.33%	7.84%
Operating Expenses	$6.089M	$1.230M	$5.096M
YoY Change	19.48%	38.2%	20.31%
Operating Profit	-$5.896M	-$1.200M	-$4.935M
YoY Change	19.48%	39.53%	18.02%
Interest Expense	$3.862M	-$1.130M	$3.129M
YoY Change	23.42%	162.79%	214.59%
% of Operating Profit
Other Income/Expense, Net	-$3.651M	$50.00K	-$3.139M
YoY Change	16.29%	25.0%	-3267.35%
Pretax Income	-$9.547M	-$2.280M	-$8.074M
YoY Change	18.23%	80.95%	59.04%
Income Tax
% Of Pretax Income
Net Earnings	-$9.547M	-$2.230M	-$8.074M
YoY Change	18.24%	78.4%	59.04%
Net Earnings / Revenue	-1849.43%	-3185.71%	-2872.35%
Basic Earnings Per Share
Diluted Earnings Per Share	-$92.15K	-$24.42K	-$89.15K
COMMON SHARES
Basic Shares Outstanding	98.94M		87.94M
Diluted Shares Outstanding

Balance Sheet

Concept	2017	2016 Q4	2016
SHORT-TERM ASSETS
Cash & Short-Term Investments	$990.5K	$1.910M	$1.910M
YoY Change	-48.15%	8.52%	8.34%
Cash & Equivalents	$990.5K	$1.910M	$1.910M
Short-Term Investments
Other Short-Term Assets	$20.00K	$0.00	$4.090K
YoY Change	389.0%	-100.0%	-91.68%
Inventory	$53.97K	$34.45K	$34.45K
Prepaid Expenses
Receivables	$94.41K	$67.99K	$67.99K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.159M	$2.017M	$2.017M
YoY Change	-42.54%	6.64%	6.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$108.9K	$59.32K	$59.32K
YoY Change	83.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$227.7K	$36.73K	$36.73K
YoY Change	519.96%	91.73%	91.7%
Total Long-Term Assets	$336.6K	$96.04K	$96.05K
YoY Change	250.42%	401.35%	401.57%
TOTAL ASSETS
Total Short-Term Assets	$1.159M	$2.017M	$2.017M
Total Long-Term Assets	$336.6K	$96.04K	$96.05K
Total Assets	$1.495M	$2.113M	$2.113M
YoY Change	-29.22%	10.6%	10.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$224.1K	$22.23K	$200.1K
YoY Change	12.0%	-87.26%	-38.43%
Accrued Expenses	$0.00	$80.00K	$80.00K
YoY Change	-100.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$50.00K	$50.00K
YoY Change	-100.0%
Long-Term Debt Due	$3.992M	$160.0K	$161.1K
YoY Change	2377.91%
Total Short-Term Liabilities	$4.216M	$1.155M	$1.155M
YoY Change	265.08%	151.04%	151.04%
LONG-TERM LIABILITIES
Long-Term Debt	$689.3K	$5.251M	$1.728M
YoY Change	-60.12%	61.76%	459.37%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$689.3K	$5.251M	$1.728M
YoY Change	-60.12%	61.76%	459.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.216M	$1.155M	$1.155M
Total Long-Term Liabilities	$689.3K	$5.251M	$1.728M
Total Liabilities	$5.600M	$2.883M	$3.438M
YoY Change	62.88%	274.92%	120.59%
SHAREHOLDERS EQUITY
Retained Earnings		-$91.92M
YoY Change		9.32%
Common Stock		$62.18K
YoY Change		8.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.104M	-$1.325M	-$1.325M
YoY Change
Total Liabilities & Shareholders Equity	$1.495M	$2.113M	$2.113M
YoY Change	-29.22%	10.6%	10.6%

Cashflow Statement

Concept	2017	2016 Q4	2016
OPERATING ACTIVITIES
Net Income	-$9.547M	-$2.230M	-$8.074M
YoY Change	18.24%	78.4%	59.04%
Depreciation, Depletion And Amortization	$30.00K	$10.00K	$13.74K
YoY Change	118.4%		25.79%
Cash From Operating Activities	-$4.284M	-$920.0K	-$3.721M
YoY Change	15.13%	70.37%	97.57%
INVESTING ACTIVITIES
Capital Expenditures	$28.67K	$0.00	-$61.93K
YoY Change	-146.3%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$29.00K	$0.00	-$61.93K
YoY Change	-53.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$511.0K		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.373M	1.120M	3.971M
YoY Change	-15.06%	-37.08%	12.41%
NET CHANGE
Cash From Operating Activities	-4.284M	-920.0K	-3.721M
Cash From Investing Activities	-29.00K	0.000	-61.93K
Cash From Financing Activities	3.373M	1.120M	3.971M
Net Change In Cash	-940.0K	200.0K	188.2K
YoY Change	-599.56%	-83.87%	-88.59%
FREE CASH FLOW
Cash From Operating Activities	-$4.284M	-$920.0K	-$3.721M
Capital Expenditures	$28.67K	$0.00	-$61.93K
Free Cash Flow	-$4.313M	-$920.0K	-$3.659M
YoY Change	17.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2017	blgo	Cash Provided By Financing Activities CashProvidedByFinancingActivities	3462785
CY2016	blgo	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	2818271
CY2017	blgo	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	510000
CY2016	blgo	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	2383545
CY2017	blgo	Class Of Warrant Or Right Expired During Period ClassOfWarrantOrRightExpiredDuringPeriod	250000
CY2016	blgo	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	6822855
CY2017	blgo	Class Of Warrant Or Right Issued During Period ClassOfWarrantOrRightIssuedDuringPeriod	2829703
CY2016	blgo	Class Of Warrant Or Right Prior Year Extensions ClassOfWarrantOrRightPriorYearExtensions	4634637
CY2015Q4	blgo	Consulting Services Monthly Payment ConsultingServicesMonthlyPayment	23438
CY2015Q4	blgo	Consulting Services Period Of Services ConsultingServicesPeriodOfServices	P4Y
CY2016	blgo	Cumulative Effect Of Change In Account Of Derivative Liability CumulativeEffectOfChangeInAccountOfDerivativeLiability
CY2017	blgo	Cumulative Effect Of Change In Account Of Derivative Liability CumulativeEffectOfChangeInAccountOfDerivativeLiability	663560
CY2017	blgo	Cumulative Effect Of New Accounting Principle During The Period CumulativeEffectOfNewAccountingPrincipleDuringThePeriod	663560
CY2016	blgo	Deemed Dividend For The Change In Accounting For Derivative Liability DeemedDividendForTheChangeInAccountingForDerivativeLiability	-234604
CY2017	blgo	Deemed Dividend For The Change In Accounting For Derivative Liability DeemedDividendForTheChangeInAccountingForDerivativeLiability	-429215
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	322717
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	105877
CY2016Q4	us-gaap	Debt Current DebtCurrent	560000
CY2017Q4	us-gaap	Debt Current DebtCurrent	5248847
CY2016	blgo	Deferred Offering Cost Expense DeferredOfferingCostExpense
CY2017	blgo	Deferred Offering Cost Expense DeferredOfferingCostExpense	10818
CY2016Q4	blgo	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent
CY2017Q4	blgo	Deferred Offering Costs Noncurrent DeferredOfferingCostsNoncurrent	195182
CY2016Q4	blgo	Discount On Convertible Notes Payable Current DiscountOnConvertibleNotesPayableCurrent	398910
CY2017Q4	blgo	Discount On Convertible Notes Payable Current DiscountOnConvertibleNotesPayableCurrent	1257182
CY2016	blgo	Deemed Dividends DeemedDividends
CY2017	blgo	Deemed Dividends DeemedDividends	343916
CY2016Q4	blgo	Discount On Convertible Notes Payable Net Of Current Portion DiscountOnConvertibleNotesPayableNetOfCurrentPortion	3522497
CY2017Q4	blgo	Discount On Convertible Notes Payable Net Of Current Portion DiscountOnConvertibleNotesPayableNetOfCurrentPortion	850000
CY2017	blgo	Equity Increase Decrease Dividends Deemed Due To A New Accounting Principle Adoption EquityIncreaseDecreaseDividendsDeemedDueToANewAccountingPrincipleAdoption	0
CY2017	blgo	Net Operating Loss Carryforward Expiration Term NetOperatingLossCarryforwardExpirationTerm	P20Y
CY2017Q4	blgo	Number Of Wholly Owned Subsidiaries NumberOfWhollyOwnedSubsidiaries	7
CY2016	blgo	Proceeds From Sale Of Convertible Notes Payable ProceedsFromSaleOfConvertibleNotesPayable	2307000
CY2017	blgo	Proceeds From Sale Of Convertible Notes Payable ProceedsFromSaleOfConvertibleNotesPayable	1798700
CY2016	blgo	Profit Loss Including Deemed Dividends For The Change Accounting For Derivative Liability ProfitLossIncludingDeemedDividendsForTheChangeAccountingForDerivativeLiability	-8074335
CY2017	blgo	Profit Loss Including Deemed Dividends For The Change Accounting For Derivative Liability ProfitLossIncludingDeemedDividendsForTheChangeAccountingForDerivativeLiability	-9546519
CY2017Q4	blgo	Repayments Of Line Of Credit Including Accrued Interest RepaymentsOfLineOfCreditIncludingAccruedInterest	51907
CY2017	blgo	Share Based Compensation Arrangementby Share Based Payment Award Fair Value Assumptions Forfeiture Rate ShareBasedCompensationArrangementbyShareBasedPaymentAwardFairValueAssumptionsForfeitureRate	0
CY2016	blgo	Stock Issued During Period Shares Exercise Of Warrants StockIssuedDuringPeriodSharesExerciseOfWarrants	2818271
CY2017	blgo	Stock Issued During Period Shares Exercise Of Warrants StockIssuedDuringPeriodSharesExerciseOfWarrants	510000
CY2016	blgo	Stock Issued During Period Shares Services Equipment And Payable Settlements StockIssuedDuringPeriodSharesServicesEquipmentAndPayableSettlements	2342264
CY2017	blgo	Stock Issued During Period Shares Services Equipment And Payable Settlements StockIssuedDuringPeriodSharesServicesEquipmentAndPayableSettlements	2420821
CY2017	blgo	Stock Issued During Period Value Employee Agreement StockIssuedDuringPeriodValueEmployeeAgreement	0
CY2016	blgo	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	864009
CY2017	blgo	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	153000
CY2017	blgo	Stock Issued During Period Value Financing Fees StockIssuedDuringPeriodValueFinancingFees	304500
CY2017	blgo	Stock Issued During Period Value Paid For Interest StockIssuedDuringPeriodValuePaidForInterest	674310
CY2016	blgo	Tax Credit Income TaxCreditIncome
CY2017	blgo	Tax Credit Income TaxCreditIncome	71130
CY2017	blgo	Valuation Allowance Percentage ValuationAllowancePercentage	1
CY2017Q4	blgo	Working Capital WorkingCapital	3056927
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	200103
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	224105
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	22231
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	171872
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	67994
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	94413
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	80000
CY2017Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-81694
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-62489
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90609774
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97093144
CY2016	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	751113
CY2017	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1103090
CY2016	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3006325
CY2017	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1145383
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2500
CY2016	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2610764
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3058108
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10920
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10920
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	22104817
CY2017Q4	us-gaap	Assets Assets	1495420
CY2016Q4	us-gaap	Assets Assets	2112726
CY2017Q4	us-gaap	Assets Current AssetsCurrent	1158843
CY2016Q4	us-gaap	Assets Current AssetsCurrent	2016682
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	990457
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1763114
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1910153
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	147039
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-919696
CY2017Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13779438
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	20035114
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00067
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00067
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	92975970
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	104164465
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	62179
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	69871
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7880858
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9098099
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-234604
CY2017	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-429215
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-8115462
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9527314
CY2017Q4	us-gaap	Contractual Obligation ContractualObligation	1125024
CY2016Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5250668
CY2017Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1539271
CY2017Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	6788118
CY2016Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	560000
CY2017Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5248847
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	19205
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4.60
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15887
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29841
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29841
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13736
CY2016Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	663560
CY2017Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2016Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.55
CY2016Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	5860668
CY2017Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	6788118
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	11100000
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-41127
CY2016	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	171800
CY2017	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants
CY2016	us-gaap	Gross Profit GrossProfit	175229
CY2016	us-gaap	Interest Paid Net InterestPaidNet	6731
CY2017	us-gaap	Interest Paid Net InterestPaidNet	8708
CY2017	us-gaap	Gross Profit GrossProfit	193496
CY2016Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2017	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	7681
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	5350
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-124880
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	114402
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	26563
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	28919
CY2016	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-135000
CY2017	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits
CY2016	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	80000
CY2017	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-80000
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2989
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19527
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-14235
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	22432
CY2017	us-gaap	Interest Expense InterestExpense	3862173
CY2016	us-gaap	Interest Expense InterestExpense	3129104
CY2016	us-gaap	Interest Expense Debt InterestExpenseDebt	3129364
CY2017	us-gaap	Interest Expense Debt InterestExpenseDebt	3862173
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4215770
CY2016Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	137500
CY2017Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	1485
CY2017Q4	us-gaap	Line Of Credit LineOfCredit	0
CY2016Q2	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.18
CY2016Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	50000
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5250668
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1539271
CY2016Q4	us-gaap	Minority Interest MinorityInterest	554969
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	40372
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	50748
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19891
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19869
CY2016Q4	us-gaap	Inventory Net InventoryNet	34446
CY2017Q4	us-gaap	Inventory Net InventoryNet	53973
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	14555
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	34104
CY2016	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	993078
CY2017	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1095623
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	88749
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	183401
CY2016Q4	us-gaap	Liabilities Liabilities	2882924
CY2017Q4	us-gaap	Liabilities Liabilities	4905041
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2112726
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1495420
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1154753
CY2017Q4	us-gaap	Minority Interest MinorityInterest	694699
CY2017	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	40000
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3971009
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3372785
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-61931
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28671
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3720912
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4283015
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7839731
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9117304
CY2017	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	1020400
CY2016Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2017	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-4934861
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-5895025
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	444733
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	300000
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	190753
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	88632
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	165348
CY2017Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	52900000
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	36729
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	32530
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-41127
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	19205
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3139474
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3651494
CY2016	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	3006325
CY2017	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	1145383
CY2016	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	61931
CY2017	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	28671
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	28671
CY2016	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders
CY2017	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	40000
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00067
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00067
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4089
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20000
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	511085
CY2016	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity
CY2017	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	750000
CY2016Q2	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	300000
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	250000
CY2016	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	500000
CY2017	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable
CY2016	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	864009
CY2017	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	153000
CY2017	us-gaap	Profit Loss ProfitLoss	-9546519
CY2016	us-gaap	Profit Loss ProfitLoss	-8074335
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108865
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	59315
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2500
CY2016Q3	us-gaap	Share Price SharePrice	0.70
CY2017Q4	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	50000
CY2016	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit
CY2017	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	50000
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1381956
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1629580
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101204846
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-91915426
CY2016	us-gaap	Revenue From Grants RevenueFromGrants	161430
CY2017	us-gaap	Revenue From Grants RevenueFromGrants	139549
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	55000
CY2017	us-gaap	Royalty Revenue RoyaltyRevenue
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	226106
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	503982
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet	516213
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	281106
CY2016	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet
CY2017	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	12231
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3714398
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4429100
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	751113
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	1103090
CY2017Q4	us-gaap	Share Price SharePrice	0.41
CY2016Q4	us-gaap	Share Price SharePrice	0.86
CY2016Q4	us-gaap	Share Price SharePrice	0.83
CY2017Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.42
CY2017Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.42
CY2017Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.394
CY2016	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	589371
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	891250
CY2016	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	993078
CY2017	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	461313
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	511085
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-1325167
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-4104320
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-770198
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3409621
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1141368
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic;">Use of Estimates </div></div></div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and revenues and expenses during the period reported. Actual results could differ from those estimates. Estimates are used when accounting for stock-based transactions, debt transactions, derivative liabilities, allowance for <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">bad debt, asset depreciation and amortization, and payroll taxes, among others. </div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The methods, estimates and judgments we use in applying these most critical accounting policies have a significant impa<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">ct on the results of our financial statements.</div></div></div></div></div></div>
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87936783
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98941169

Files In Submission

Name	View Source	Status
0001437749-18-004890-index-headers.html	Edgar Link	pending
0001437749-18-004890-index.html	Edgar Link	pending
0001437749-18-004890.txt	Edgar Link	pending
0001437749-18-004890-xbrl.zip	Edgar Link	pending
blgo-20171231.xml	Edgar Link	completed
blgo-20171231.xsd	Edgar Link	pending
blgo-20171231_cal.xml	Edgar Link	unprocessable
blgo-20171231_def.xml	Edgar Link	unprocessable
blgo-20171231_lab.xml	Edgar Link	unprocessable
blgo-20171231_pre.xml	Edgar Link	unprocessable
blgo20171231_10k.htm	Edgar Link	pending
ex_107883.htm	Edgar Link	pending
ex_108120.htm	Edgar Link	pending
ex_108157.htm	Edgar Link	pending
ex_108158.htm	Edgar Link	pending
ex_108168.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLGO
BIOLARGO, INC. Stock $blgo

2017 Form 10-K Financial Statement

#000143774918004890 Filed on March 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLGO BIOLARGO, INC. Stock $blgo

2017 Form 10-K Financial Statement

#000143774918004890 Filed on March 16, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLGO
BIOLARGO, INC. Stock $blgo